Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Torri

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Psychopharmacology|November 19, 2011
Comment on: "Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice" (Magnani P, Conforti A, Zanolin E, Marzotto M and Bellavite P, Psychopharmacology, 2010)Luigi Cervo, Valter Torri
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 24, 2005
Cyproterone acetate in the therapy of prostate carcinomaValter Torri, Irene Floriani
The New England Journal of Medicine|May 15, 2024
Neoadjuvant or Perioperative Approach in Lung CancerMarina Chiara Garassino, Valter Torri
The Lancet. Oncology|January 21, 2014
Afatinib for lung cancer: let there be light?Marina C Garassino, Valter Torri
The New England Journal of Medicine|July 7, 2009
Cetuximab for metastatic colorectal cancerSilvio Garattini, Valter Torri, Irene Floriani
Endocrine|March 1, 2016
In memoriam: Dr. Irene Claudia Floriani (1964-2016)Valter Torri, Lital Hollander, Gherardo Mazziotti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 18, 2011
Switch maintenance versus second-line treatment in non-small cell lung cancerAntonio Rossi, Valter Torri, Cesare Gridelli
The New England Journal of Medicine|April 16, 2008
Paclitaxel plus bevacizumab for metastatic breast cancerAntonio Rossi, Valter Torri, Cesare Gridelli
The New England Journal of Medicine|March 30, 2007
Bevacizumab for non-small-cell lung cancerMarina Chiara Garassino, Lital Hollander, Valter Torri
Journal of the National Cancer Institute|June 13, 2019
RE: Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and PrognosisSerenai Di Cosimo, Valter Torri, Luca Porcu
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Psychopharmacology|November 19, 2011
Comment on: "Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice" (Magnani P, Conforti A, Zanolin E, Marzotto M and Bellavite P, Psychopharmacology, 2010)Luigi Cervo, Valter Torri
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 24, 2005
Cyproterone acetate in the therapy of prostate carcinomaValter Torri, Irene Floriani
The New England Journal of Medicine|May 15, 2024
Neoadjuvant or Perioperative Approach in Lung CancerMarina Chiara Garassino, Valter Torri
The Lancet. Oncology|January 21, 2014
Afatinib for lung cancer: let there be light?Marina C Garassino, Valter Torri
The New England Journal of Medicine|July 7, 2009
Cetuximab for metastatic colorectal cancerSilvio Garattini, Valter Torri, Irene Floriani
Endocrine|March 1, 2016
In memoriam: Dr. Irene Claudia Floriani (1964-2016)Valter Torri, Lital Hollander, Gherardo Mazziotti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 18, 2011
Switch maintenance versus second-line treatment in non-small cell lung cancerAntonio Rossi, Valter Torri, Cesare Gridelli
The New England Journal of Medicine|April 16, 2008
Paclitaxel plus bevacizumab for metastatic breast cancerAntonio Rossi, Valter Torri, Cesare Gridelli
The New England Journal of Medicine|March 30, 2007
Bevacizumab for non-small-cell lung cancerMarina Chiara Garassino, Lital Hollander, Valter Torri
Journal of the National Cancer Institute|June 13, 2019
RE: Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and PrognosisSerenai Di Cosimo, Valter Torri, Luca Porcu
Pageof 23